Cargando…

How mind-body therapies might reduce pathological features of Alzheimer’s disease

Detalles Bibliográficos
Autores principales:	Hüttenrauch, Melanie, Castro-Obregón, Susana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2022
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8820700/ https://www.ncbi.nlm.nih.gov/pubmed/35017434 http://dx.doi.org/10.4103/1673-5374.332146

Ejemplares similares

Intrathecal corticosteroids might slow Alzheimer’s disease progression
por: Alisky, Joseph Martin
Publicado: (2008)

How Might Cocaine Interfere with Brain Development?
por: Hyman, Steven E
Publicado: (2008)

Might Fibroblasts from Patients with Alzheimer’s Disease Reflect the Brain Pathology? A Focus on the Increased Phosphorylation of Amyloid Precursor Protein Tyr(682) Residue
por: Iannuzzi, Filomena, et al.
Publicado: (2021)

How useful are biomarkers for the diagnosis of Alzheimer’s disease and especially for its therapy?
por: Valenza, Marta, et al.
Publicado: (2022)

Mind the mind: How to effectively communicate about cognition in social–ecological systems research
por: Bercht, Anna Lena, et al.
Publicado: (2018)

How would preclinical Alzheimer’s disease (AD pathology) occur? An insight from a genomic instability mouse model
por: Rao, Chinthalapally V., et al.
Publicado: (2021)

Advancing the Genetics of Lewy Body Disorders with Disease‐Modifying Treatments in Mind
por: Levy, Gilberto, et al.
Publicado: (2022)

Effect of the Ketone Body, D-β-Hydroxybutyrate, on Sirtuin2-Mediated Regulation of Mitochondrial Quality Control and the Autophagy–Lysosomal Pathway
por: Gómora-García, Juan Carlos, et al.
Publicado: (2023)

Mind-Body Wellness: A Complement to Dental Education and Professional Development
por: Pastan, Christina DiBona
Publicado: (2021)

Expanding the Mind–Body–Environment Connection to Enhance the Development of Cultural Humility
por: Soulé, Isabelle, et al.
Publicado: (2022)

If ineffective levels of transforming growth factors and their receptor account for old age being a risk factor for Alzheimer's disease, then increasing TGFBR2 might be therapeutic
por: Fessel, Jeffrey
Publicado: (2020)

How wasting is saving: Weight loss at altitude might result from an evolutionary adaptation
por: Murray, Andrew J, et al.
Publicado: (2014)

Nurture might be nature: cautionary tales and proposed solutions
por: Hart, Sara A., et al.
Publicado: (2021)

Evidence-Based Mind-Body Interventions for Children and Adolescents with Functional Neurological Disorder
por: Kozlowska, Kasia, et al.
Publicado: (2023)

The viral hypothesis: how herpesviruses may contribute to Alzheimer’s disease
por: Wainberg, Michael, et al.
Publicado: (2021)

Alzheimer’s and Consciousness: How Much Subjectivity Is Objective?
por: Bajic, Vladan, et al.
Publicado: (2021)

Mixed pathologies and neural reserve: Implications of complexity for Alzheimer disease drug discovery
por: Bennett, David A.
Publicado: (2017)

Aquaporin 5 in Alzheimer’s disease: a link between oral and brain pathology?
por: Municio, Cristina, et al.
Publicado: (2022)

Advancing combination therapy for Alzheimer's disease
por: Salloway, Stephen P., et al.
Publicado: (2020)

Putative roles of cathepsin B in Alzheimer's disease pathology: the good, the bad, and the ugly in one?
por: Bernstein, Hans-Gert, et al.
Publicado: (2018)

Misfolded amyloid-β strains and their potential roles in the clinical and pathological variability of Alzheimer’s disease
por: Kelley, Sara, et al.
Publicado: (2022)

On the Origins of a Species: What Might Explain the Rise of Candida auris?
por: Jackson, Brendan R., et al.
Publicado: (2019)

Complement pathway in Alzheimer’s pathology and retinal neurodegenerative disorders – the road ahead
por: Mirzaei, Mehdi, et al.
Publicado: (2019)

Innovative Reports on the Effects of Anabolic Androgenic Steroid Abuse—How to Lose Your Mind for the Love of Sport
por: Stojko, Michał, et al.
Publicado: (2023)

An aging, pathology burden, and glial senescence build-up hypothesis for late onset Alzheimer’s disease
por: Lau, Victor, et al.
Publicado: (2023)

Coping with COVID-19 in Sub-Saharan Africa: What Might the Future Hold?
por: Mennechet, Franck J. D., et al.
Publicado: (2020)

Detection and clearance in Alzheimer’s disease: leading with illusive chemical, structural and morphological features of the targets
por: Gales, Luís
Publicado: (2023)

The Perspective of Psychological Action Mechanism of Mindfulness Meditation: Mindfulness Meditation Blurs the Transparent Boundary Between the Unconscious and the Conscious Mind
por: Ahmed, Darya Rostam
Publicado: (2023)

Targeting immunometabolic pathways for combination therapy in Alzheimer's disease
por: Erichsen, Jennifer, et al.
Publicado: (2023)

Editorial: The Variable Mind? How Apparently Inconsistent Effects Might Inform Model Building
por: Amenta, Simona, et al.
Publicado: (2016)

Lingo-1: a novel target in therapy for Alzheimer's disease?
por: Fernandez-Enright, Francesca, et al.
Publicado: (2016)

How Much Can the USA Reduce Health Care Costs by Reducing Smoking?
por: Hall, Wayne, et al.
Publicado: (2016)

Luteolin Reduces Alzheimer’s Disease Pathologies Induced by Traumatic Brain Injury
por: Sawmiller, Darrell, et al.
Publicado: (2014)

Imaging tau pathology in Alzheimer’s disease with positron emission tomography: lessons learned from imaging-neuropathology validation studies
por: Moscoso, Alexis, et al.
Publicado: (2022)

Digital phenotyping: An equal opportunity approach to reducing disparities in Alzheimer's disease and related dementia research
por: Britton, Gabrielle B., et al.
Publicado: (2023)

Group Nature-Based Mindfulness Interventions: Nature-Based Mindfulness Training for College Students with Anxiety
por: Vitagliano, Luke A., et al.
Publicado: (2023)

Hyperbaric oxygen therapy as a new treatment approach for Alzheimer’s disease
por: Shapira, Ronit, et al.
Publicado: (2018)

The promise of microRNA-based therapies in Alzheimer’s disease: challenges and perspectives
por: Walgrave, Hannah, et al.
Publicado: (2021)

Biomarker-guided drug therapy: personalized medicine for treating Alzheimer’s disease
por: Syal, Charvi, et al.
Publicado: (2021)

Direct oral anticoagulants: a new therapy against Alzheimer’s disease?
por: Grossmann, Klaus
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_si6jkjqrp1i8kmvqcr63gu8r5v